Lianhua Qingwen exerts anti-liver cancer effects and synergistic efficacy with sorafenib through PI3K/AKT pathway: Integrating network pharmacology, molecular docking, and experimental validation
This study broadens the potential application of LHQW and provides insights for liver cancer treatment.PMID:38493972 | DOI:10.1016/j.gene.2024.148383
Source: Gene - Category: Genetics & Stem Cells Authors: Jinrui Wei Xuqi Zhao Fuli Long Kunpeng Tian Lichuan Wu Source Type: research
More News: Cancer | Cancer & Oncology | China Health | Drugs & Pharmacology | Food and Drug Administration (FDA) | Genetics | Influenza | Liver | Oseltamivir | Study | Tamiflu | Urology & Nephrology